Daniel van den Bergh(61)

Photo of Daniel van den Bergh, Principal at Kaiser Permanente Ventures
Oakland, California
$5.0m - $12.0m
Enterprise healthcare IT, digital health, healthcare services, medical technology
We don't deploy capital in: (1) new molecule development, (2) outside of the US, (3) in businesses that compete directly with Kaiser Permanente (Medicare Advantage plans, for example).
CompanyDeal TypeAmountDate
OrdrSeries B$33.5MMar 2020
NuvoloSeries B$12M (Lead)Jul 2019
NextHealth TechnologiesSeries B$20MMar 2019
Collective Medical TechnologiesSeries A$47.5MNov 2017
ProtenusSeries A$7M (Lead)Jul 2017
QuantiaMDSeries E$12M (Lead)Aug 2013
Sotera WirelessSeries D1$15M (Lead)May 2013
PrognosSeries B$15MMay 2013
NuPathePIPE$28MOct 2012
Putney VetSeries C$21M (Lead)Sep 2011
The Wharton School MBA Healthcare and entrepreneurship
Cornell University BS Biological Engineering
No media found for Daniel van den Bergh.
Photo of Amy	 Belt Raimundo, Managing Director at Kaiser Permanente Ventures

Kaiser Permanente Ventures

Photo of Liz Rockett, Kaiser Permanente Ventures

Kaiser Permanente Ventures

Photo of Ambar Bhattacharyya, Maverick Capital

Maverick Capital

Photo of Noah Knauf, General Partner at Bond